An in vitro system to study tumor dormancy and the switch to metastatic growth

Journal of Visualized Experiments

Volumn , Issue 54, 2011, Pages

  Barkan, Dalit ^a   Green, Jeffrey E ^b  

^a UNIVERSITY OF HAIFA   (Israel)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

3D culture; Breast cancer; Cancer recurrence; Issue 54; Medicine; Metastasis; Reconstituted basement membrane extract (BME); Tumor dormancy

Indexed keywords

EID: 80355145642     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/2914     Document Type: Article

References (20)

1. Aguirre-Ghiso, J. A. Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer. 7, 834-846 doi:nrc2256 [pii] 10.1038/nrc2256 (2007).
2. Pantel, K. & Woelfle, U. Micrometastasis in breast cancer and other solid tumors. J Biol Regul Homeost Agents. 18, 120-125 (2004).
3. Naumov, G. N. et al. Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat. 82, 199-206 (2003).
4. Klein, C. A. Framework models of tumor dormancy from patient-derived observations. Curr Opin Genet Dev. doi:S0959-437X(10)00189-9 [pii] 10.1016/j.gde.2010.10.011 (2010).
5. Naumov, G.N., et al. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res. 62, 2162-2168 (2002).
6. Townson, J.L. & Chambers, A.F. Dormancy of solitary metastatic cells. Cell Cycle. 5, 1744-1750, doi:2864 [pii] (2006).
7. Chambers, A. F., Groom, A.C., & MacDonald, I.C. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer. 2, 563-572 (2002).
8. Pantel, K., et al. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells. J Natl Cancer Inst. 85, 1419-1424 (1993).
9. Demicheli, R. Tumour dormancy: findings and hypotheses from clinical research on breast cancer. Semin Cancer Biol. 11, 297-306 (2001).
10. Braun, S., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med. 353, 793-802 (2005).
11. Pantel, K., Alix-Panabieres, C. & Riethdorf, S. Cancer micrometastases. Nat Rev Clin Oncol. 6, 339-351 doi:nrclinonc.2009.44 [pii] 10.1038/nrclinonc.2009.44 (2009).
12. Goss, P. E. & Chambers, A. F. Does tumour dormancy offer a therapeutic target? Nat Rev Cancer. 10, 871-877 doi:nrc2933 [pii] 10.1038/nrc2933 (2010).
13. Mendoza, A, et al.Modeling metastasis biology and therapy in real time in the mouse lung. J Clin Invest. 120, 2979-2988 doi:40252 [pii] 10.1172/JCI40252 (2010).
14. Naumov, G.N., et al. A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst. 98, 316-325 (2006).
15. Barkan, D., et al. Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res. 70, 5706-5716, doi:0008-5472.CAN-09-2356 [pii] 10.1158/0008-5472.CAN-09-2356 (2010).
16. Barkan, D., Green, J.E., & Chambers, A.F. Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth. Eur J Cancer. doi:S0959-8049(10)00154-1 [pii] 10.1016/j.ejca.2010.02.027 (2010).
17. Barkan, D., et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 68, 6241-6250 doi:68/15/6241 [pii] 10.1158/0008-5472.CAN-07-6849 (2008).
18. Debnath, J., Muthuswamy, S.K., & Brugge, J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods. 30, 256-268 (2003).
19. Morris, V.L., et al. Mammary carcinoma cell lines of high and low metastatic potential differ not in extravasation but in subsequent migration and growth. Clin Exp Metastasis. 12, 357-367 (1994).
20. Khanna, C., et al. The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis. Nat Med. 10, 182-186 (2004).